secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-12-10T23:59:59+00:00
Accession:  0001683168-24-008607
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma annual meeting: all director nominees elected with >130M votes, auditor ratified
--------------------------------------------------------------------------------

- Dr. Steve Slilaty, Dr. Merzouki, Dr. Kiderchah, Mr. Natan, Dr. Keller each elected with over 130M votes FOR.
- Ratification of Bush & Associates CPA LLC as auditor: 130,089,305 FOR, 15,456 AGAINST, 11,725 abstain.
- Meeting held December 10, 2024; all director nominees were elected with zero broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824008607/0001683168-24-008607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824008607/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer